Texas is helping shape the future of psychedelic therapies. Here's how they work and what access could look like.
The US Food and Drug Administration (FDA) has issued warning letters to several firms that have violated current good ...
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for ...
Stocktwits on MSN
REPL nosedives as FDA chief stands firm against melanoma treatment: ‘I don’t work for Replimune’
The FDA Commissioner reportedly clarified that the FDA made no “corrupt sweetheart deals.” ・Makary’s clarification comes on the heels of Health Secretary Robert F. Kennedy Jr. pinning the ...
Casgevy’s approval changed the sickle cell disease landscape. Developed by Vertex Pharmaceuticals and CRISPR Therapeutics, the therapy showed that the disease could be tackled at its genetic root, ...
Based on FDA Office of Generic Drugs guidance previously announced, NRx has transmitted an initial GMP manufacturing order to ...
Researcher Jeffrey L. Cummings M.D., ScD, from the Kirk Kerkorian School of Medicine at UNLV, has released his annual report ...
The Food and Drug Administration blocked the publication of studies that tracked the safety of the COVID-19 and shingles ...
Suneel Kamath, MD, knows too well the sense of helplessness that comes with living through what he calls “the doughnut hole.” ...
US drug pricing policy and Congressional Budget Office (CBO) model of the Build Back Better Act examining pharmaceutical R&D ...
GLP-1 receptor agonists may not raise the risk for diabetic ketoacidosis or pancreatitis among adults with type 1 diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results